AtriCure, Inc. - Common Stock (NQ:ATRC)

55.81 +2.97 (+5.62%)

Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AtriCure, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

AtriCure to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference

August 31, 2021

From AtriCure, Inc.

Via Business Wire

Return on Capital Employed Insights for AtriCure ↗

August 20, 2021

After pulling data from Benzinga Pro it seems like during Q2, AtriCure's (NASDAQ:ATRC) reported sales totaled $71.38 million. Despite a 5.09% in earnings, the company posted a...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021 ↗

August 05, 2021

Upgrades Stephens & Co. upgraded the previous rating for Roku Inc (NASDAQ:

Via Benzinga

Earnings Scheduled For April 27, 2021 ↗

April 27, 2021

Companies Reporting Before The Bell • Camden National (NASDAQ:CAC) is projected to report quarterly earnings at $1.01 per share on revenue of $45.73 million. •...

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

April 23, 2021

On Friday morning, 152 companies hit new 52-week highs. Things to Consider: The largest company by market cap to hit a new 52-week high was ASML Holding (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

AtriCure, inc (ATRC) Q2 2021 Earnings Call Transcript ↗

August 04, 2021

ATRC earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

AtriCure Reports Second Quarter 2021 Financial Results

August 04, 2021

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate at the Canaccord 41st Annual Growth Conference

July 30, 2021

From AtriCure, Inc.

Via Business Wire

AtriCure to Announce Second Quarter 2021 Financial Results

July 07, 2021

From AtriCure, Inc.

Via Business Wire

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data ↗

July 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

AtriCure Names Two New Members to the Board of Directors

June 15, 2021

From AtriCure, Inc.

Via Business Wire

Expert Ratings for AtriCure ↗

May 26, 2021

Analysts have provided the following ratings for AtriCure (NASDAQ:ATRC) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 2 0 0...

Via Benzinga

The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO ↗

July 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test ↗

July 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

Topics Product Recall

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout ↗

June 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

May 26, 2021

Morgan Stanley boosted the price target for Intuit Inc. (NASDAQ: INTU) from $470 to $511. Intuit shares rose 1% to $443.50 in pre-market trading. Keybanc raised the price target...

Via Benzinga

The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs ↗

April 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 29, 2021

Gainers Galera Therapeutics (NASDAQ:GRTX) stock rose 21.78% to $8.05 during Thursday's regular session. As of 12:32 EST, Galera Therapeutics's stock is trading at...

Via Benzinga

AtriCure’s EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients

April 29, 2021

From AtriCure, Inc.

Via Business Wire

65 Biggest Movers From Yesterday ↗

April 30, 2021

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) jumped 33.1% to settle at $3.34 on Thursday as the company said it has been named as sponsor related to 4 SPACs. Takung Art Co., Ltd. (...

Via Benzinga

Here's Why AtriCure Stock Is Moving Today ↗

April 28, 2021

AtriCure Inc. (NASDAQ: ATRC) shares are trading higher by 6.35% at $69.03 after the company reported better-than-expected first-quarter EPS and sales results. Oppenheimer analyst...

Via Benzinga

54 Stocks Moving In Thursday's Mid-Day Session ↗

April 29, 2021

Gainers Willamette Valley Vineyards, Inc. (NASDAQ: WVVI) climbed 40.5% to $14.39. Dolphin Entertainment, Inc. (NASDAQ: DLPN) shares gained 23.1% to $14.14. Dolphin Entertainment...

Via Benzinga

AtriCure Inc (ATRC) Q1 2021 Earnings Call Transcript ↗

April 28, 2021

ATRC earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

AtriCure: Q1 Earnings Insights ↗

April 27, 2021

Shares of AtriCure (NASDAQ:ATRC) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 11.11% year over year...

Via Benzinga

AtriCure Reports First Quarter 2021 Financial Results

April 27, 2021

From AtriCure, Inc.

Via Business Wire

The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗

April 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

Preview: AtriCure's Earnings ↗

April 26, 2021

AtriCure (NASDAQ:ATRC) announces its next round of earnings this Tuesday, April 27. Here is Benzinga's everything-that-matters guide for this Tuesday's Q1 earnings...

Via Benzinga

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.